Active substance
Disulfiram
- SFDA 1
- US FDA 14
- US price lines 2
- NHS prices 1
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| TETMASOL SOAP | 5 % | Cutaneous emulsion · Topical | 1 Box | SAR 1.45 | Generic · Prescription | AstraZeneca | Withdrawn by MAH · Not Marketed |
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| DISULFIRAM | 250MG; 500MG | tablet · oral | SIGMAPHARM LABS LLC | Prescription | 28 Mar 2011 |
| DISULFIRAM | 250MG; 500MG | tablet · oral | CHARTWELL MOLECULES | Prescription | 31 Dec 2012 |
| DISULFIRAM | 250MG | tablet · oral | ALVOGEN | Prescription | 8 Aug 2013 |
| ANTABUSE | 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**; 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | tablet · oral | TEVA WOMENS | Discontinued | 28 Aug 1951 |
| DISULFIRAM | 250MG | tablet · oral | WATSON LABS | Discontinued | 31 Mar 1981 |
| DISULFIRAM | 500MG | tablet · oral | WATSON LABS TEVA | Discontinued | 31 Mar 1981 |
| DISULFIRAM | 250MG | tablet · oral | WATSON LABS | Discontinued | 5 Aug 1983 |
| DISULFIRAM | 500MG | tablet · oral | WATSON LABS | Discontinued | 5 Aug 1983 |
| ANTABUSE | 250MG | tablet · oral | ODYSSEY PHARMS | Discontinued | 8 Dec 1983 |
| ANTABUSE | 500MG | tablet · oral | ODYSSEY PHARMS | Discontinued | 8 Dec 1983 |
| DISULFIRAM | 250MG | tablet · oral | STRIDES PHARMA INTL | Discontinued | 14 Aug 1984 |
| DISULFIRAM | 500MG | tablet · oral | STRIDES PHARMA INTL | Discontinued | 14 Aug 1984 |
| DISULFIRAM | 250MG; 500MG | tablet · oral | HIKMA PHARMS | Discontinued | 5 Feb 2014 |
| DISULFIRAM | 250MG; 500MG | tablet · oral | NATCO PHARMA USA | Discontinued | 4 Mar 2015 |
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| US NADAC | DISULFIRAM 250 MG TABLET | $1.82342 | per EA | 23 Sep 2026 |
| US NADAC | DISULFIRAM 500 MG TABLET | $13.31433 | per EA | 23 Sep 2026 |
| NHS Drug Tariff | Disulfiram 200mg tablets | £89.72 | 50 tablet | 1 Oct 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.